Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma

NCT00002599 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

750

Enrollment

OTHER_GOV

Sponsor class

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: recombinant interferon alfa
BIOLOGICAL: sargramostim
DRUG: carmustine
DRUG: cyclophosphamide
DRUG: doxorubicin hydrochloride
DRUG: melphalan
DRUG: methylprednisolone
DRUG: prednisone
DRUG: vincristine sulfate
RADIATION: low-LET cobalt-60 gamma ray therapy
RADIATION: low-LET photon therapy

Sponsor

Medical Research Council